3 results
Next to cardiovascular risk factors (main objectives: body composition and lipid profile; secondary objectives: remainder) we investigate the effect of GH treatment on glucose metabolism, physical performance, and neuropsychological functioning of…
Evaluate the performance of Ambu® aScope* 4 Cysto and aView* Urologia for direct visualization and treatment of the urethra and bladder.Evaluate the patient tolerance to the procedure and the procedural time of Ambu® aScope* 4 Cysto and aView*…
Primary objectiveThe primary objective of this study is to confirm non-inferiority of once-weekly somapacitan compared with once-daily Norditropin® in terms of longitudinal growth measured by height velocity at week 52 in children with each of the…